260 related articles for article (PubMed ID: 28843957)
21. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
[TBL] [Abstract][Full Text] [Related]
22. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
[TBL] [Abstract][Full Text] [Related]
23. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia.
Wick EC; LeBlanc RE; Ortega G; Robinson C; Platz E; Pardoll DM; Iacobuzio-Donahue C; Sears CL
Inflamm Bowel Dis; 2012 Jul; 18(7):1267-74. PubMed ID: 22021169
[TBL] [Abstract][Full Text] [Related]
24. Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment.
Habermann J; Lenander C; Roblick UJ; Krüger S; Ludwig D; Alaiya A; Freitag S; Dümbgen L; Bruch HP; Stange E; Salo S; Tryggvason K; Auer G; Schimmelpenning H
Scand J Gastroenterol; 2001 Jul; 36(7):751-8. PubMed ID: 11444475
[TBL] [Abstract][Full Text] [Related]
25. The surgical treatment of inflammatory bowel disease-associated dysplasia.
Connelly TM; Koltun WA
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):307-21; quiz 322. PubMed ID: 23639089
[TBL] [Abstract][Full Text] [Related]
26. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
27. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations.
Melville DM; Jass JR; Shepherd NA; Northover JM; Capellaro D; Richman PI; Lennard-Jones JE; Ritchie JK; Andersen SN
Gastroenterology; 1988 Sep; 95(3):668-75. PubMed ID: 3396815
[TBL] [Abstract][Full Text] [Related]
28. Colorectal Neoplasia and Inflammatory Bowel Disease.
Cannon J
Surg Clin North Am; 2015 Dec; 95(6):1261-9, vii. PubMed ID: 26596926
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
30. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
[TBL] [Abstract][Full Text] [Related]
31. Dysplasia in inflammatory bowel diseases.
Mescoli C; Albertoni L; D'incá R; Rugge M
Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
[TBL] [Abstract][Full Text] [Related]
32. [The malignant side of chronic inflammatory bowel disease].
West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
[TBL] [Abstract][Full Text] [Related]
33. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
34. Dysplasia in inflammatory bowel disease.
Greenson JK
Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
[TBL] [Abstract][Full Text] [Related]
35. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
[TBL] [Abstract][Full Text] [Related]
36. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
37. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
[TBL] [Abstract][Full Text] [Related]
38. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia.
Löfberg R; Broström O; Karlén P; Ost A; Tribukait B
Gastroenterology; 1992 Apr; 102(4 Pt 1):1149-54. PubMed ID: 1551524
[TBL] [Abstract][Full Text] [Related]
39. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
Krugliak Cleveland N; Colman RJ; Rodriquez D; Hirsch A; Cohen RD; Hanauer SB; Hart J; Rubin DT
Inflamm Bowel Dis; 2016 Mar; 22(3):631-7. PubMed ID: 26658214
[TBL] [Abstract][Full Text] [Related]
40. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
